Literature DB >> 21745001

Monte Carlo simulation of irradiation and killing in three-dimensional cell populations with lognormal cellular uptake of radioactivity.

Roger W Howell1, Didier Rajon, Wesley E Bolch.   

Abstract

PURPOSE: The biological response of tissue exposed to radiations emitted by internal radioactivity is often correlated with the mean absorbed dose to a tissue element. However, experimental studies show that even when the mean absorbed dose to the tissue element is constant, the response of the cell population within the tissue element can vary significantly depending on the distribution of radioactivity at the cellular and multicellular levels. The present work develops theoretical models to simulate these observations.
MATERIALS AND METHODS: Two theoretical models were created to simulate experimental three-dimensional cell culture models with homogeneous and inhomogeneous tissue environments. The cells were assigned activities according to lognormal distributions of an alpha particle emitter or a monoenergetic electron emitter. Absorbed doses to the cell nuclei were assessed with point-kernel geometric-factor and Electron Gamma Shower version nrc (EGSnrc) Monte Carlo radiation transport simulations, respectively. The self- and cross-dose to individual cell nuclei were calculated and a Monte Carlo method was used to determine their fate. Survival curves were produced after tallying the live and dead cells.
RESULTS: Both percent cells labeled and breadth of lognormal distribution affected the dose distribution at the cellular level, which in turn, influenced the shape of the cell survival curves.
CONCLUSIONS: Multicellular Monte Carlo dosimetry-models offer improved capacity to predict response to radiopharmaceuticals compared to approaches based on mean absorbed dose to the tissue.

Entities:  

Mesh:

Year:  2011        PMID: 21745001      PMCID: PMC4029158          DOI: 10.3109/09553002.2011.602379

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  51 in total

1.  Voxel size effects in three-dimensional nuclear magnetic resonance microscopy performed for trabecular bone dosimetry.

Authors:  D A Rajon; D W Jokisch; P W Patton; A P Shah; W E Bolch
Journal:  Med Phys       Date:  2000-11       Impact factor: 4.071

2.  Radiation effects in spheroids of cells exposed to alpha emitters.

Authors:  D E Charlton
Journal:  Int J Radiat Biol       Date:  2000-11       Impact factor: 2.694

3.  Bystander effects caused by nonuniform distributions of DNA-incorporated (125)I.

Authors:  Roger W Howell; Anupam Bishayee
Journal:  Micron       Date:  2002       Impact factor: 2.251

4.  3D absorbed dose calculations based on SPECT: evaluation for 111-In/90-Y therapy using Monte Carlo simulations.

Authors:  Michael Ljungberg; Eric Frey; Katarina Sjögreen; Xiaowei Liu; Yuni Dewaraja; Sven-Erik Strand
Journal:  Cancer Biother Radiopharm       Date:  2003-02       Impact factor: 3.099

5.  Application of new imaging and calculation techniques to activity and dose assessment in the case of a 106Ru contaminated wound.

Authors:  L de Carlan; I Aubineau-Lanièce; A Lemosquet; N Borissov; J R Jourdain; D Jeanbourquin; B Le Guen; D Franck
Journal:  Radiat Prot Dosimetry       Date:  2003       Impact factor: 0.972

6.  MIRD Pamphlet No 19: absorbed fractions and radionuclide S values for six age-dependent multiregion models of the kidney.

Authors:  Lionel G Bouchet; Wesley E Bolch; H Pablo Blanco; Barry W Wessels; Jeffry A Siegel; Didier A Rajon; Isabelle Clairand; George Sgouros
Journal:  J Nucl Med       Date:  2003-07       Impact factor: 10.057

7.  Multicellular dosimetry in voxel geometry for targeted radionuclide therapy.

Authors:  A Malaroda; G D Flux; F M Buffa; R J Ott
Journal:  Cancer Biother Radiopharm       Date:  2003-06       Impact factor: 3.099

8.  A software tool for specifying voxel models for dosimetry estimation.

Authors:  Erin McKay
Journal:  Cancer Biother Radiopharm       Date:  2003-06       Impact factor: 3.099

9.  RMDP: a dedicated package for 131I SPECT quantification, registration and patient-specific dosimetry.

Authors:  Matthew J Guy; Glenn D Flux; Periklis Papavasileiou; Maggie A Flower; Robert J Ott
Journal:  Cancer Biother Radiopharm       Date:  2003-02       Impact factor: 3.099

10.  Free radical-initiated and gap junction-mediated bystander effect due to nonuniform distribution of incorporated radioactivity in a three-dimensional tissue culture model.

Authors:  A Bishayee; H Z Hill; D Stein; D V Rao; R W Howell
Journal:  Radiat Res       Date:  2001-02       Impact factor: 2.841

View more
  6 in total

1.  Survival of tumor and normal cells upon targeting with electron-emitting radionuclides.

Authors:  Didier Rajon; Wesley E Bolch; Roger W Howell
Journal:  Med Phys       Date:  2013-01       Impact factor: 4.071

2.  Redefining relative biological effectiveness in the context of the EQDX formalism: implications for alpha-particle emitter therapy.

Authors:  Robert F Hobbs; Roger W Howell; Hong Song; Sébastien Baechler; George Sgouros
Journal:  Radiat Res       Date:  2014-01       Impact factor: 2.841

3.  Predicting response of micrometastases with MIRDcell V3: proof of principle with 225Ac-DOTA encapsulating liposomes that produce different activity distributions in tumor spheroids.

Authors:  Sumudu Katugampola; Jianchao Wang; Aprameya Prasad; Stavroula Sofou; Roger W Howell
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-07-08       Impact factor: 10.057

4.  Radium-223-Induced Bystander Effects Cause DNA Damage and Apoptosis in Disseminated Tumor Cells in Bone Marrow.

Authors:  Brian S Canter; Calvin N Leung; J Christopher Fritton; Tom Bäck; Didier Rajon; Edouard I Azzam; Roger W Howell
Journal:  Mol Cancer Res       Date:  2021-05-26       Impact factor: 5.852

5.  Modeling bystander effects that cause growth delay of breast cancer xenografts in bone marrow of mice treated with radium-223.

Authors:  Didier A Rajon; Brian S Canter; Calvin N Leung; Tom A Bäck; J Christopher Fritton; Edouard I Azzam; Roger W Howell
Journal:  Int J Radiat Biol       Date:  2021-07-26       Impact factor: 3.352

6.  What is the Role of the Bystander Response in Radionuclide Therapies?

Authors:  Darren Brady; Joe M O'Sullivan; Kevin M Prise
Journal:  Front Oncol       Date:  2013-08-19       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.